We collected information about Genecentric Diagnostics Inc Hours for you. Follow the liks to find out everything about Genecentric Diagnostics Inc Hours.
GeneCentric's rT(I)ME Explorer Platform. Unwinding the complex Tumor and Immune MicroEnvironment (T(I)ME) to translate tumor biology insights into actionable genomic signatures of drug response and new target identification.Our RNA-based rT(I)ME Explorer Platform builds upon pioneering RNA-based genomic-defined cancer subtypes and immunogenomic innovations.
https://genecentric.com/about-us/
Dr. Philippe Chemla is Chief Business Officer at GeneCentric. Prior to joining GeneCentric, Dr. Chemla served as President of Diabetic Health Inc., CEO and Director at Clinical Sensors, which he negotiated the acquisition, Chief Business Officer for the David H. Murdock Research Institute, which he restructured as a commercial CRO, Vice President of Business Development at Metabolon where he ...
https://genecentric.com/our-technology/
GeneCentric’s Cancer rT(I)ME Explorer Platform builds on: 1) the pioneering tumor genomics work of co-founders, Charles Perou, PhD, and Neil Hayes, MD, MPH, MS, innovators in the molecular characterization and treatment of cancer and 2) the immunogenomic computational pipelines developed and curated by Benjamin Vincent, MD and Joel Parker, PhD.
https://www.crunchbase.com/organization/genecentric-diagnostics
Founded Date 2011. Founders Myla Lai-Goldman. Operating Status Active. Last Funding Type Series B. Also Known As GeneCentric Diagnostics. Legal Name GeneCentric Therapeutics, Inc. Company Type For Profit. Contact Email [email protected]. Phone Number 919-215-5962.
https://www.ventureradar.com/organisation/GeneCentric%20Diagnostics/1390904d-1784-43ee-818a-767bfa7cb2ba
GeneCentric Diagnostics Follow Following Location: USA. Founded in 2011. Private Company " Founded in 2011, GeneCentric is dedicated to enabling precise and effective treatment options for cancer patients through personalized molecular diagnostic assays and targeted drug development. We leverage our proprietary Cancer Subtype Platform (CSP ...
https://www.sec.gov/Archives/edgar/data/1529224/000152922417000001/xslFormDX01/primary_doc.xml
GeneCentric Diagnostics, Inc. Street Address 1 Street Address 2; 280 SOUTH MANGUM STREET: SUITE 350: City State/Province/Country ZIP/PostalCode Phone Number of Issuer; DURHAM: NORTH CAROLINA: 27701 (919) 215-5962
https://pitchbook.com/profiles/company/53673-22
Description. Developer of a molecular diagnostic platform intended to characterize tumor biology in a manner that facilitates optimal targeting of therapeutic compounds. The company's platform engages in developing tests that identify patients who would benefit from drugs that inhibit tumor growth, enabling clinicians to make a rational ...
Searching for Genecentric Diagnostics Inc Hours?
You can just click the links above. The info is collected for you.
